Why do insurers deny IVIG for PANS or PANDAS?

Most insurers consider IVIG for PANS or PANDAS off-label or investigational and deny it on that basis. The same insurers, however, routinely cover IVIG for primary immunodeficiency. So the practical key is to document an underlying immune deficiency, such as low IgG or specific antibody deficiency, and have IVIG approved and billed under that recognized indication rather than under PANS alone.

What labs help get IVIG approved?

The labs that most often turn a denial into an approval are a full immunoglobulin panel with IgG subclasses (a low IgG is a direct qualifier) and a pneumococcal vaccine-titer challenge to document specific antibody deficiency, or SPAD. Tetanus and diphtheria titers round out the picture. A documented immunodeficiency diagnosis is what supports the medical-necessity case.

How do you appeal an IVIG denial?

Read the denial letter for the exact reason and deadline, then submit a written appeal with a strong medical-necessity letter, the immune labs, and the diagnosis codes for the immune deficiency. Request a peer-to-peer review so your prescriber can speak to the insurer's medical director. If the internal appeal fails, you can request an external or independent medical review. Specialty infusion pharmacies often write and manage the appeal for your doctor to sign.

Are states passing laws requiring PANS/PANDAS coverage?

Yes. A growing number of states have passed or introduced laws requiring insurers to cover PANS and PANDAS treatment, including immunomodulatory therapies. Coverage and enforcement vary by state and plan, and self-funded employer plans are often exempt, so it is worth checking your state's current law and citing it in an appeal where it applies.

Field Guide · The Access Fight

Getting IVIG covered.
The insurance playbook.

The barrier to IVIG is almost never the medicine — it’s insurance. Insurers deny it for “PANS” (they call it off-label) but cover it for immune deficiency. So the whole game is to document the immune deficiency and get IVIG approved under THAT. Here’s the practical playbook: the qualifying labs, the medical-necessity letter, the appeal, and the state laws now changing the picture.

This is a maze families shouldn’t have to navigate alone — so here’s the map, step by step, with the people who fight it for you.

The core move, in one sentence

Insurers deny IVIG billed under “PANS” as off-label, but approve the same infusion billed under primary immunodeficiency (low IgG, SPAD, CVID). So you document the immune deficiency, get that diagnosis on paper, and have IVIG approved and billed under it. Everything below is how to do that — and this only applies where a real immune deficiency exists; it’s about getting a genuine diagnosis recognized, not inventing one.

Step 1 · Get the labs that qualify you

These are the blood tests that turn a denial into an approval. Ask your doctor to run them up front, before any prior-auth attempt:

Test	What it shows	Why it matters for coverage
Immunoglobulin panel + IgG subclasses	IgG, IgA, IgM, IgE, and IgG subclasses 1–4	A low IgG is a direct qualifier (hypogammaglobulinemia / CVID).
Pneumococcal vaccine-titer challenge	Check titers, give Pneumovax 23 (PPSV23), recheck in ~4–6 weeks	A poor response = SPAD (specific antibody deficiency) — the classic PANS-kid immune diagnosis insurance covers IVIG for.
Tetanus + diphtheria titers	Protein-vaccine response	Rounds out the immune picture and strengthens the case.

Who to see first: a board-certified clinical immunologist — ideally PANS-aware — not a cash-pay-only specialist. The immunologist takes insurance, runs this exact workup, and can put the immunodeficiency diagnosis on paper. On the first call, ask: “Do you run the SPAD / immunoglobulin workup and bill IVIG under immunodeficiency?” IDF — Insurance Coverage for Ig Therapy

Step 2 · Build the medical-necessity case

Once a deficiency is documented, the medical-necessity letter is what the insurer reviews. A strong one ties everything together:

The immunodeficiency diagnosis with the supporting labs (low IgG and/or failed pneumococcal response = SPAD) and the right ICD-10 codes — this is the indication insurers recognize.
The clinical picture — recurrent or severe infections, the neuropsychiatric impairment, abrupt onset, and the functional impact on the child.
What’s already been tried and failed — antibiotics, anti-inflammatories, and why IVIG is the appropriate next step.
References to recognized criteria — the immunodeficiency guidelines and, where relevant, the PANS Consortium treatment guidance for the immune picture. PANS Consortium, Part II — Immunomodulatory Therapies

The shortcut most families miss: the specialty / infusion pharmacy’s patient advocate will often write the medical-necessity and appeal letters for your doctor to sign, run the free benefits verification and prior authorization, and give you one coordinator to call. Pharmacies like Nufactor, Option Care, Coram (CVS), AmeriPharma, and KabaFusion do this routinely. Nufactor service model

Step 3 · Win the prior authorization — or appeal the denial

IVIG almost always requires prior authorization. If the first answer is no, a denial is the start of the process, not the end — many are overturned on appeal.

Read the denial letter carefully. It states the exact reason (e.g. “not medically necessary,” “investigational for PANS”) and the deadline to appeal. Both matter.
Reframe under immunodeficiency. If it was denied as “PANS / off-label,” the appeal’s job is to show the recognized immune-deficiency indication with the labs and codes — a different, covered basis.
Request a peer-to-peer review. Your prescriber speaks directly to the insurer’s medical director. This conversation overturns many denials and should be requested explicitly.
File the formal written appeal with the medical-necessity letter, labs, and records — let the infusion pharmacy’s team draft it.
Escalate to external / independent review if the internal appeal fails. An independent medical reviewer outside the insurer re-decides — a real and often successful step.

IDF — prior-authorization & appeal tips · IDF — navigating insurance

Step 4 · Know your state’s PANS/PANDAS coverage law

The legal landscape is shifting in families’ favor. A growing number of states have passed or introduced laws requiring insurers to cover PANS/PANDAS treatment, including immunomodulatory therapies like IVIG — advocacy groups have been pushing these state mandates for years.

How to use this:

Check whether your state has a current PANS/PANDAS coverage law — and if it does, cite it by name in your appeal. A state mandate is powerful leverage.
Know the limits. Coverage and enforcement vary by state and plan, and self-funded employer plans are often exempt from state insurance mandates (they’re governed federally), so the law may not bind your specific plan — check.
The immunodeficiency route still matters even where a law exists — documenting the immune diagnosis remains the most reliable path, with the state law as added leverage.

ASPIRE — PANS/PANDAS legislation tracker · PANDAS Network — state legislation

If money’s tight while you fight

Denied high-dose IVIG can run into the tens of thousands per round out of pocket — which is exactly why the workup-for-approval matters. While the prior-auth is in motion, these can bridge the gap:

Co-pay & manufacturer assistance — the PAN Foundation primary-immunodeficiency fund and the immunoglobulin makers’ patient-assistance programs (CSL Behring, Takeda, Grifols, Octapharma) can cover co-pays or product. PAN — Primary Immunodeficiency fund
The Immune Deficiency Foundation (IDF) — insurance-navigation help, a model coverage policy, and an appeals toolkit. primaryimmune.org
The infusion pharmacy’s financial coordinator — they often know which assistance program fits and enroll you.

Free Synthesis

Don’t do this maze alone. Plan B helps you see exactly which labs qualify your child, what the medical-necessity case should say, and which practitioners and assistance programs get IVIG covered — so you stop guessing and start moving. Your first Synthesis is free.

Start your free Synthesis → Parent education, not medical or legal advice. You stay in charge.

Where to go from here

IVIG, fully deconstructed — who qualifies, infusion day, side effects, and the studies.
IVIG for autism — who it may help, and the honest evidence.
How to get a PANS diagnosis — the workup and tests that build the case.
The full map of PANS treatment options — where IVIG sits among the rest.

Bottom line

IVIG coverage isn’t about the medicine — it’s about which diagnosis it’s billed under. Insurers deny it for “PANS” but cover it for immune deficiency, so the playbook is: run the immunoglobulin + SPAD workup, document the deficiency, build the medical-necessity letter, win the prior-auth or appeal it (peer-to-peer, then external review), and cite your state’s PANS/PANDAS coverage law where one exists. Let an infusion pharmacy’s advocate do the heavy paperwork, and use assistance funds to bridge. This is parent education, not medical or legal advice — check your specific plan and state.

How Plan B stays honest

Plan B does not partner with drug companies or doctors, and we never endorse anyone whose healing isn’t verified by families. We show you the options and how to vet them yourself — and we’re building parent verification: look up a clinic or practitioner and see real family reviews before you trust them. Universal bad reviews? Skip.

← Back to the Field Guide

Getting IVIG covered.The insurance playbook.